Disease & disorder
optic papillitis
MONDO:0006879
Swelling of the optic disk, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause optic atrophy and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
5 shownOptic Nerve Sheath Diameter in Hypertensive EmergencyNCT06286696 · 2024-11-01
NOT_YET_RECRUITINGThe Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial PressureNCT06027567 · 2022-09-02
COMPLETEDEndovascular Stenting Treatment for Patients With Internal Jugular Vein StenosisNCT03373292 · 2018-01-01
UNKNOWNCerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment ScalesNCT03273179 · 2017-06-01
UNKNOWNaICP in Glaucoma and PapilledemaNCT02410148 · 2015-04-01
UNKNOWNDrugs being studied
Research locations
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.